Breakthrough FDA Designation


“80% of Patients See Their Disease Go Into Remission” – Groundbreaking FDA-Approved Therapy to Be Administered In New Locations

“80% of Patients See Their Disease Go Into Remission” – Groundbreaking FDA-Approved Therapy to Be Administered In New Locations

Chimeric Antigen Receptor T (cell), or CAR-T therapy, is part of an emerging and revolutionary new breed of treatments designed to fight cancer by using the patient’s own immune system to...

read more
Page 1 of 212